DK262585D0 - Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser - Google Patents

Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser

Info

Publication number
DK262585D0
DK262585D0 DK262585A DK262585A DK262585D0 DK 262585 D0 DK262585 D0 DK 262585D0 DK 262585 A DK262585 A DK 262585A DK 262585 A DK262585 A DK 262585A DK 262585 D0 DK262585 D0 DK 262585D0
Authority
DK
Denmark
Prior art keywords
compounds
salts
polypeptides
procedures
preparation
Prior art date
Application number
DK262585A
Other languages
English (en)
Other versions
DK262585A (da
Inventor
Bruce Hill Frank
Allen Howard Pekar
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DK262585D0 publication Critical patent/DK262585D0/da
Publication of DK262585A publication Critical patent/DK262585A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK262585A 1984-06-14 1985-06-12 Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser DK262585A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/620,781 US4581165A (en) 1984-06-14 1984-06-14 Anti-diabetic compounds

Publications (2)

Publication Number Publication Date
DK262585D0 true DK262585D0 (da) 1985-06-12
DK262585A DK262585A (da) 1985-12-15

Family

ID=24487362

Family Applications (1)

Application Number Title Priority Date Filing Date
DK262585A DK262585A (da) 1984-06-14 1985-06-12 Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser

Country Status (7)

Country Link
US (1) US4581165A (da)
EP (1) EP0171887B1 (da)
JP (1) JPS6110599A (da)
AT (1) ATE86668T1 (da)
CA (1) CA1244365A (da)
DE (1) DE3587164T2 (da)
DK (1) DK262585A (da)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888414A (en) * 1987-04-09 1989-12-19 Board Of Regents, University Of Texas System Insulin-binding peptides and uses thereof
US4992418A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
US4992417A (en) * 1987-07-17 1991-02-12 Mount Sinai School Of Medicine Superactive human insulin analogues
US5208217A (en) * 1989-04-20 1993-05-04 Mount Sinai School Of Medicine Of The City University Of New York Hepatospecific insulin analogues
JPH05252941A (ja) * 1991-08-12 1993-10-05 Sakai Enetsukusu Kk 動物細胞培養用担体
TW224471B (da) * 1991-11-26 1994-06-01 Lilly Co Eli
SE520392C2 (sv) * 1996-09-27 2003-07-01 Creative Peptides Sweden Ab C Specifika peptider för behandling av diabetes mellitus
DE60032944T2 (de) 1999-12-30 2007-10-18 Corning Inc. Sekundärbeschichtung für lichtleitfasern
WO2001049629A1 (en) 1999-12-30 2001-07-12 Corning Incorporated Fast curing primary optical fiber coating
AU1582701A (en) 1999-12-30 2001-07-16 Corning Incorporated Optical fibers prepared with a primary coating composition including a monomer with a pendant hydroxyl functional group
US6775451B1 (en) 1999-12-30 2004-08-10 Corning Incorporated Secondary coating composition for optical fibers
AU3262001A (en) 1999-12-30 2001-07-16 Corning Incorporated Composition containing tackifier and method of modifying time-sensitive rheological properties of optical fiber coating
CA2402191C (en) 2000-03-24 2012-03-13 Genentech, Inc. Use of insulin for the treatment of cartilagenous disorders
US6584263B2 (en) 2000-07-26 2003-06-24 Corning Incorporated Optical fiber coating compositions and coated optical fibers
US6553169B2 (en) 2000-11-29 2003-04-22 Corning Incorporated Optical fiber coating compositions and coated optical fibers
US6602601B2 (en) 2000-12-22 2003-08-05 Corning Incorporated Optical fiber coating compositions
US20030077059A1 (en) * 2001-03-13 2003-04-24 Ching-Kee Chien Optical fiber coating compositions
US6628875B2 (en) 2001-07-20 2003-09-30 Corning Incorporated Optical fibers possessing a primary coating with a higher degree of cure and methods of making
US7715675B2 (en) * 2003-07-18 2010-05-11 Corning Incorporated Optical fiber coating system and coated optical fiber
US7050688B2 (en) * 2003-07-18 2006-05-23 Corning Cable Systems Llc Fiber optic articles, assemblies, and cables having optical waveguides
US9678247B2 (en) 2012-05-08 2017-06-13 Corning Incorporated Primary optical fiber coating composition containing non-radiation curable component
US9488774B2 (en) 2014-04-01 2016-11-08 Corning Incorporated Primary optical fiber coating composition containing non-radiation curable component
US9708491B2 (en) 2014-06-04 2017-07-18 Corning Incorporated Optical fiber coating and composition
US9891379B2 (en) 2014-11-14 2018-02-13 Corning Incorporated Optical fiber coating compositions with acrylic polymers
US20160177092A1 (en) 2014-12-18 2016-06-23 Corning Incorporated Optical fiber coating composition with non-reactive reinforcing agent
US10640654B2 (en) 2015-12-07 2020-05-05 Corning Incorporated Optical fiber coating and composition with UV-absorbing additive

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3209184A1 (de) * 1982-03-13 1983-09-15 Hoechst Ag, 6230 Frankfurt Verfahren zur umwandlung von praeproinsulinanaloga zu insulinen

Also Published As

Publication number Publication date
EP0171887A3 (en) 1989-01-25
DK262585A (da) 1985-12-15
JPS6110599A (ja) 1986-01-18
ATE86668T1 (de) 1993-03-15
US4581165A (en) 1986-04-08
EP0171887B1 (en) 1993-03-10
DE3587164T2 (de) 1993-07-15
CA1244365A (en) 1988-11-08
DE3587164D1 (de) 1993-04-15
EP0171887A2 (en) 1986-02-19

Similar Documents

Publication Publication Date Title
DK262585D0 (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
IT8919316A0 (it) Benzoderivati di composti eterociclici contenenti azoto.
DK262485A (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK397387A (da) Carbostyrilderivater og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DE69132435D1 (de) Inhibitoren retroviraler Proteasen
IT8467225A1 (it) Composti di solfonio, procedimento di preparazione di detti composti e composizioni farmacologiche contenenti i composti stessi.
DK167187D0 (da) Carbostyrilderivater og salte deraf, fremgangsmaade til fremstilling af saadanne forbindelser og laegemiddel indeholdende disse
ES552585A0 (es) Procedimiento para la union quimica de compuestos de moldeo.
DK451686A (da) Arylmethylazoler og deres salte, fremgangsmaade til fremstilling deraf, midler indeholdende disse forbindelser samt deres anvendelse
FI864190A7 (fi) Heterocykliska foereningar.
DK262685A (da) Polypeptider og salte deraf samt fremgangsmaade til fremstilling af saadanne forbindelser
DK160763C (da) Imidazooe1,5-aaapyridiner og salte deraf samt deres 5,6,7,8-tetrahydroderivater, farmaceutiske praeparater indeholdende disse forbindelser samt anvendelse af forbindelserne
DK162390C (da) Makrocycliske forbindelser, fermenteringsfremgangsmaade til fremstilling heraf, mikroorganisme til brug ved fremgangsmaaden, farmaceutiske praeparater indeholdende forbindelserne, samt anvendelse af forbindelserne til fremstilling af farmaceutiske praeparater og plantebeskyttelsesmidler
FI860909A7 (fi) Heterocykliska foereningar.
ES524439A0 (es) Procedimiento de obtencion de los 2-amino 5- (aralcoil piperidino alcoil) amino 1,4-diazoles
DK46086D0 (da) Prinycinkomponenter eller salte deraf, fremgangsmaade til deres fremstilling samt deres anvendelse som antibiotika
DK319384D0 (da) 1-0-alkyl-3-amino-propan-1,2-diol-2-0-phospholipider, fremgangsmaade til deres fremstilling samt farmaceutiske praeparater indeholdende disse
NO863616D0 (no) Fremgangsmaate for fremstilling av n-sulfamyl-3-(2-guanidino-thiazolo-4-yl-methylthio)-propionamid.
DK423284A (da) Naphthalenylimidazopyridin og derivater heraf samt fremgangsmaade til fremstilling af saadanne forbindelser
FI865220A7 (fi) Menetelmä sulfinyyli- ja sulfonyylisubstituoitujen 3-bentsatsepiinien valmistamiseksi.
DK192890D0 (da) 24r-scumnol, fremgangsmaade til fremstilling heraf samt anvendelse af samme
NO863785L (no) Sporlegger for langrennsloeyper.
DK433882A (da) 1,2,3-thiadiazol-5-yl-urinstofderivater, fremgangsmaade til fremstilling af disse forbindelser samt midler indeholdende disse forbindelser med vaekstregulerende og afbladende virkning
FI864641L (fi) Heterocykliska foereningar.
IT8419896A0 (it) Procedimento per il condizionamento e la disidratazione di fanghi primari contenenti solfuri.

Legal Events

Date Code Title Description
ATS Application withdrawn